Reinhart Partners’s Gilead Sciences GILD Stock Holding History

Reinhart Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,245	Closed	-$354K	–	103
2016 Q2	$354K	Buy	4,245 +1,545	+57%	+$137K	0.04%	86
2016 Q1	$248K	Sell	2,700 -1,340	-33%	-$121K	0.03%	99
2015 Q4	$409K	Sell	4,040 -6,450	-61%	-$671K	0.04%	93
2015 Q3	$1.03M	Buy	+10,490	New	+$1.17M	0.1%	91

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Reinhart Partners's GILD Position: Q3 2016 in Review

Reinhart Partners sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 4,245 shares — an estimated $354K sold.

Reinhart Partners first reported a position in GILD in Q3 2015 and held it in 4 quarters. The position peaked at $1.03M in Q3 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Reinhart Partners reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Reinhart Partners sold 4,245 Gilead Sciences shares in Q3 2016, an estimated $354K.
Reinhart Partners first reported a position in Gilead Sciences in Q3 2015 and held it in 4 quarters.
Reinhart Partners's Gilead Sciences position peaked at $1.03M in Q3 2015.
1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Reinhart Partners's 13F filing for Q3 2016, filed 19 Oct 2016.